Just a reminder, webcast available at opk website, investor relations.
Retail leaves fairly fast, hedge funds double down and dig their heels in. Last Q they pushed this down to 2.98, then when we see the fund filings the market manipulation is obvious. Deerfieild doubling up from 12.2 million to 23m is an example of a fund taking advantage of this fact. Deerfield can not buy more, they are right near 10% but other funds will push it down to add. I would like to see it base here in the 8's for a week or two before the next leg up, but the funds will dictate what the stock does.
YAH I R GOOD, at technicals, hold for 10 years, chart will prove U right. The only thing I don't like is traders, who think talking about chalk will get u in and out only to lose on big moves.
thanks: Arry moved farther and faster, so did opk, but true to form, both are matching their timeline, eom. I said before, opk runs first, arry then blows opk out of the water short term, opk then wins long term, we will see.
Arry under performs long term only cause it gets bought out, Frost will never sell, but build.
Top 10 holders own about 90 million of 140m shares about 65% of all shares. Though it might seem like a lot, at the current price it is only about 650 million dollars. For some funds it is a drop in the bucket, for Deerfield it is their second largest holding and they bought all their shares in the past 2 quarters. They basically hold only biotech stocks, with very few other sectors. So they have a BIG bet on arry. Second largest position out of roughly 140, near 10% of outstanding shares, hope they ask for a seat on the board.
Now we know why they manipulated it down to 3.00, so Deerfield could double their position from 12.2m, to 23m. 23m is just shy of 10%.
No, that was Fidelity filing because they own 5% or more shares. The top 8 funds combined own about 46% of the company, each of those funds has to file. So far Black Rock, T Row Price, and Fidelity filed.
You know yourself better than anyone else possibly could, so if you say your an " IDIOT!!! " no one here has the RIGHT to disagree. So idiot it is.
Investor relations has never responded to any emails I have sent, I have never called, though I guess I could have. My emails did not really call for a response.
Conference is in NY, if you hear Phil Frost and Tim Cook are ringing the bell at the NY stock exchange go all in, lol. Shameless pump, lol.
Feb 25 2:35 pm ET
Hedge fund pounding at it's best, first batch, 13.88, second at 13.69. They will try keeping it below this range.
If they partnered for just the blood test device but shouldered roll out, and further development for shared profit, they would have Frost's undivided attention. That plus an upfront payment of course. This is all speculative and wishful thinking, but not that far fetched either. If I was still dating I would WANT it plus a hundred or so cassettes.
Chimera puts out info on catalysts for drug companies. Without solid word from opk stating they submitted we really do not know. Chimera combs over biotech earnings calls to pick out the catalysts, and you can have access to their research for a fee. So Chimera is repeating what was said in the Nov call, nda by Q1, which ends March 31 the date they gave.
Opk does have an ios app actually for 4k score, but I am thinking in the " WHAT IF. " What if Apple's Tim Cook decided to invest and help develop this dongle to combat AIDS in a humanitarian move. With their distribution channel they could hit underdeveloped countries in months. Every active dater in the developed world would have this device in their glove compartment. The incidence of AIDS would plummet. THIS is the perfect use of Apples billions. They could sell it here, and donate them to Africa.
Samuel K. Sia:
“Well we have been working with a Company called Opko Health as our partner and they are one of the co-authors on this paper. And we certainly been talking to a number of companies, diagnostic companies as well as some pharmaceutical companies. What’s interesting now is, with the increasing interest in using smartphones for health, there is an increasing number of consumer electronic companies from Silicon Valley that are interested in this.”
Is Cupertino Ca. in silicon valley? Come on Apple you can afford the investment with all that cash.
Leerink's last price target for Arry has not been raised and sits at 6.00 since last AUG. Figure they will upgrade Monday.
His wording was not clear, whatsoever. I figure he meant the addressable market because that is what is usually stated. He did say that for two indications Arry could be first to market.
If I understood Ron correctly, the market for the NVS drugs is 2 billion. What he did not make clear to me was is that the revenue he felt arry could generate, or is that the total potential market where they would get a piece. Any investors here have a better understanding?